WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Bioscience Neurolucida
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, D. H.
Right arrow Articles by McIntosh, T. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, D. H.
Right arrow Articles by McIntosh, T. K.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 13, 5383-5392, Copyright © 1993 by Society for Neuroscience


ARTICLE

Effects of the excitatory amino acid receptor antagonists kynurenate and indole-2-carboxylic acid on behavioral and neurochemical outcome following experimental brain injury

DH Smith, K Okiyama, MJ Thomas and TK McIntosh
Division of Neurosurgery, University of Pennsylvania, Philadelphia 19104.

The overactivation of the NMDA receptor is thought to be a major contributor to the pathophysiologic sequelae of traumatic brain injury (TBI), which commonly includes memory dysfunction. Uniquely, potentiation of the NMDA receptor is dependent on the binding of glycine to a distinct site on the receptor. Despite the potential role of the NMDA receptor in the development of post-TBI cognitive deficits, no studies to date have evaluated the efficacy of NMDA receptor antagonists on memory dysfunction after brain injury. Moreover, glycine site antagonists have not been employed as potential therapeutic agents in models of TBI. In the present study, we evaluated the effects of two glycine site antagonists, kynurenate (KYNA) and indole-2-carboxylic acid (I2CA), on memory and motor dysfunction, cerebral edema formation, and changes in regional total tissue brain [Na], [K], [Ca], [Mg], and [Zn], following lateral fluid-percussion brain injury in the rat. We found that both KYNA (300 mg/kg) and I2CA (50 mg/kg and 20 mg/kg) administered 15 min postinjury dramatically attenuated trauma-induced cognitive dysfunction (p < 0.01). In addition, both compounds improved neurologic motor deficits measured at 2 weeks following injury (p < 0.05). KYNA (300 mg/kg) reduced edema in the cortex, hippocampus, and thalamus, while I2CA (20 mg/kg) reduced edema formation only in the thalamus. Differential effects of KYNA and I2CA on cation concentrations were also noted. KYNA attenuated the postinjury increase in regional tissue [Ca]; however, it had little effect on other cation concentrations. I2CA reversed the postinjury regional increases in [Na] and decreases in [K], [Mg], and [Zn], but had little effect on [Ca] changes. These results indicate that KYNA and I2CA may have differential, but beneficial effects on both behavioral and neurochemical sequelae of TBI.


This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
C. M. Norris, E. M. Blalock, O. Thibault, L. D. Brewer, G. V. Clodfelter, N. M. Porter, and P. W. Landfield
Electrophysiological Mechanisms of Delayed Excitotoxicity: Positive Feedback Loop Between NMDA Receptor Current and Depolarization-Mediated Glutamate Release
J Neurophysiol, November 1, 2006; 96(5): 2488 - 2500.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Rossi, Q. Han, J. Li, J. Li, and M. Rizzi
Crystal Structure of Human Kynurenine Aminotransferase I
J. Biol. Chem., November 26, 2004; 279(48): 50214 - 50220.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Garattini
Glutamic Acid, Twenty Years Later
J. Nutr., April 1, 2000; 130(4): 901 - 901.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
W. Danysz and C. G. Parsons
Glycine and N-Methyl-D-Aspartate Receptors: Physiological Significance and Possible Therapeutic Applications
Pharmacol. Rev., December 1, 1998; 50(4): 597 - 664.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. R. Kreutz, T. M. Bockers, J. Bockmann, C. I. Seidenbecher, B. Kracht, C. K. Vorwerk, J. Weise, and B. A. Sabel
Axonal Injury Alters Alternative Splicing of the Retinal NR1 Receptor: the Preferential Expression of the NR1b Isoforms Is Crucial for Retinal Ganglion Cell Survival
J. Neurosci., October 15, 1998; 18(20): 8278 - 8291.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
P. Bittigau and C. Ikonomidou
Topical Review: Glutamate in Neurologic Diseases
J Child Neurol, November 1, 1997; 12(8): 471 - 485.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
A. Mukhin, L. Fan, and A. I. Faden
Activation of Metabotropic Glutamate Receptor Subtype mGluR1 Contributes to Post-Traumatic Neuronal Injury
J. Neurosci., October 1, 1996; 16(19): 6012 - 6020.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-